CI · The Cigna Group
$305.78
-0.38% last session
End-of-day data · close of 2026-10-26
Market cap
$81B
Enterprise value
$106B
Trailing P/E
12.6
Forward P/E
9.1
Dividend yield
2.0%
Beta
0.30
Avg volume
2M
Employees
66K
Daily Change %
-0.38%
5 Days Change
-3.20%
10 Days Change
1.15%
30 Days Change
12.41%
60 Days Change
10.25%
Month to Day Change
14.11%
Year to Day Change
12.98%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CI
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-02
Latest call per bank · past 12 months
RBC Capital
Outperform$337
+10.2% vs priceJefferies
Hold$307
+0.4% vs priceWells Fargo
Equal-Weight$307
+0.4% vs priceBarclays
Equal-Weight$310
+1.4% vs priceUBS
Buy$400
+30.8% vs priceMorgan Stanley
Overweight$361
+18.1% vs priceDeutsche Bank
Hold$302
-1.2% vs priceGoldman Sachs
Buy$330
+7.9% vs priceJP Morgan
Overweight$375
+22.6% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-02 | Piper Sandler | Maintains | Overweight | $346 → $370 |
| 2026-10-01 | RBC Capital | Reiterates | Outperform | $337 |
| 2026-08-04 | Jefferies | Downgrade | Buy → Hold | $336 → $307 |
| 2026-08-03 | Raymond James | Downgrade | Strong Buy → Outperform | $350 → $320 |
| 2026-07-31 | Wells Fargo | Maintains | Equal-Weight | $305 → $307 |
| 2026-07-31 | Guggenheim | Maintains | Buy | $338 → $361 |
| 2026-07-31 | Barclays | Maintains | Equal-Weight | $304 → $310 |
| 2026-07-09 | Bernstein | Maintains | Outperform | $371 → $381 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-26
- neutral: RSI (14): RSI is 64 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 8.5% above the 50-day MA ($281.76).
- bullish: Price vs 200-day MA: Trading 9.7% above the 200-day MA ($278.83).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+2.48) — short-term momentum is improving.
- bullish: 52-week range: Price is within 5% of the 52-week high ($315.88).
CI Price Chart
Loading chart for CI…
Fundamentals
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
More in Healthcare Plans
UNH
UnitedHealth Group Incorporated
$369B 26.9% YTD
CVS
CVS Health Corporation
$118B 20.2% YTD
ELV
Elevance Health, Inc.
$94B 24.8% YTD
HUM
Humana Inc.
$50B 64.1% YTD
CNC
Centene Corporation
$34B 65.3% YTD
MOH
Molina Healthcare Inc
$11B 18.0% YTD
OSCR
Oscar Health, Inc.
$10B 116.4% YTD
ALHC
Alignment Healthcare, Inc.
$2B -60.1% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.